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Since the  classic works of Ellermann  and  Bang on the avian leukosis  (1) 
and of Rous on the chicken sarcoma  (2),  the concept that viral agents may 
play a  role in  the  induction of many neoplastic diseases  has  been seriously 
considered. Shope's discovery of the infectious papilloma agent of rabbits (3) 
and Bittner's of the carcinoma-inducing agent in the milk of certain strains 
of mice (4) have given further credence to this theory. 
In recent years there has been much evidence pointing to the viral causation of 
leukemia in mice. Gross (5-7) has reported that many newborn mice of a low leukemic 
strain,  when inoculated with  ceU-free material  obtained from leukemic  organs  of 
either AK or Css high leukemic strains of mice, develop leukemia, sarcomas, or parotid 
gland tumors upon reaching maturity. Stewart (8, 9) and WooUey (10) have carried 
out experiments  confirming the presence  of such  oncogenic agents in AK leukemia 
extracts. Schwartz et al. (11) recently reported the accelerated development of leuke- 
mia in approximately 50 per cent of young adult AK mice 2 to 12 weeks after their 
inoculation with filtrates prepared from the brains of leukemic AK mice. 
The present communication describes a  filterable agent obtained from the 
spleen of a  leukemic Swiss mouse and  the malignant  proliferative disease of 
the hematopoietic system which it consistently produces on serial transmission 
to adult mice. 
Origin of the Agent 
In the course of examination of the EhrUch ascites tumor with the electron 
microscope it was noted that the  cytoplasm of some of the tumor cells con- 
tained  particles  of  Constant  diameter in  close array  (12).  The  similarity of 
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these particles to those seen in virus-infected  cells prompted an investigation 
of the possible viral etiology of the tumor. It was during this study that the 
agent  now  to  be  described was  isolated. 
The Ehrllch ascites carcinoma was originally obtained from Dr. K. Suguira of the Sloan- 
Kettering Institute. It is maintained by routine passage in Swiss mice by the intraperitoneal 
injection at 14 day intervals of diluted ascitic fluid containing approximately one million tumor 
cells. A cell-free extract of the tumor was prepared as follows. 
Fourteen days after the injection of mice with the Ehtlich ascites tumor, the ascitic fluid 
from these animals was collected and centrifuged at low speed  (500  to 1000 mp.xQ  for 10 
minutes. The supernatant was removed and discarded. The sedlmented cells were ground with 
sand in a mortar and suspended in buffered Locke-Ringer's solution.  1 With the aim of freeing 
the suspension of intact cells, the ground tumor suspension (11 ml.) was centrifuged in a Spinco 
model L at 40,000  R.p.~r. for 2 hours and the upper third of the supernatant  in the Spinco 
tubes was removed without disturbing the sedimented pellet. One tenth of I ml. of this super- 
natant fluid was injected subcutaneously into each of thirty Swiss mice less than 24 hours of 
age. After a 14 month period of observation, during which all the animals remained apparently 
healthy, these mice were sacrificed.  Microscopically and in the gross there was no evidence of 
the Ehrlich tumor in any of the thirty animals autopsied. However, it was noted at autopsy 
that six of the thirty mice had enlarged spleens and livers. Each of the six spleens was removed 
aseptically, finely minced with scissors, and suspended individually in Locke-Ringer's solution. 
Each  suspension  was injected intraperitoneally in 0.2  ml. amounts  into six groups of five 
adult Swiss albino mice each, since no suckling mice were available at the time. Four of the 
groups remained negative, but in two marked enlargement of the spleen and liver took place 
in three of the five mice injected in each group. Passages from one of these groups were dis- 
continued after the third transfer generation. Passages from the other have furnished the sub- 
ject of this report. It is now in its twenty-slxth serial transfer. 
Characteristi,  s of the Disease Studied 
Two to 3 weeks after the intraperitoneal injection of a  10 per cent suspen- 
sion of affected spleen, or of a filtrate of the suspension,  made as described 
further on, mice develop spleens so enlarged that they can be detected by ab- 
dominal palpation. The animals show no other obvious signs for 2 to 3 months 
and appear healthy until a few days before death. At this time they become 
inactive and emaciated and the fur roughens. The proportion of deaths varies 
from experiment to experiment  but is usually in excess of 85  per cent. The 
time at which death occurs after the injection of either a suspension of about 
ten million whole cells or a filtrate of the suspension is plotted in Text-fig.  1. 
There were 110 mice in each series plotted. 
As can be seen, the range in the time of death is from 30 to 100 days, with 
an occasional  animal dying earlier  or surviving longer.  The  median day of 
death,  nearly the  same  in  both  groups,  is  77  days for suspension-injected 
animals and 74 days for those which received filtrates. 
1 Locke-Ringer's solution contains 6 rag. of glucose per ml., 50/~. of penicillin per ml., and 
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The disease produced is identical as concerns incubation period and hematological changes, 
whether intact cells or filtrates are injected. The white blood count--which has been taken at 
weekly intervals---generally remaln~ under 50,000 cells per ram.  s in the first 4 weeks following 
inoculation. A sharp rise occurs between the 5th and 7th week and may reach over 300,000 
cells per ram.  s terminally. At this time there is also a  marked decrease in the red blood cell 
count. Representative red and white cell counts are listed in Table I. The peripheral blood 
contains large mononudear cells with a rounded, lobed, or horseshoe shaped nucleus. (Figs. 1 
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Fzo. 1. Survival time of 110 mice after inoculation with filtrate or cells of ;-fected 
spleen. Each black dot stands for a mouse. Cumulative percentage of deaths is plotted against 
post inoculation days. 
and 2). These cells are extremely fragile and often appear smudged in smears. Their origin is 
still undetermined. Hematologists who have examined them differ as to whether they are of 
the granulocytic or monocytic series.  Nucleated red blood cells,  generally from I  to 10 per 
100 white blood cells, also appear in the peripheral blood in the term;nnl stages of the disease. 
Over 400 mice have been e~mlned to date. At autopsy of mice dead of the disease the 
liver and spleen are greatly enlarged. The spleen, for example, may weigh from 2 to 8 gm., in 
comparison with a normal spleen weight of 0.2 gin. or less. Massive peritoneal hemorrhage is 
found in approximately one-third of the animals, and in about one-half of the mice in which 
hemorrhage is found the spleen has ruptured. The lymph nodes are increased to two to three 
times normal size and are firm. Other organs appear normal in the gross.  Fig. 3 illustrates the 310  CELL-I~R-EE TRANSMISSION  OF  A  MOUSE  LEUKEMIA 
characteristic gross findings in a mouse which died of the disease. A normal mouse is shown for 
comparison. 
Microscopic examination of the organs of the diseased mice revealed that  the principal 
changes were in the bone marrow, spleen,  liver, and the peripheral blood. These organs were 
markedly infiltrated with abnormal cells. Prominent in the infiltrations was a large monouu- 
cleated cell generally resembling that in the blood, its major portion consisting of a more or 
less rounded pale nucleus having a  fine chromatin pattern.  Round the periphery was a  thin 
rim of dark blue cytoplasm. In the early stages of the process,  about 1 to 2 months after in- 
ject~on of a suspension or filtrate of spleen, decalcified sections of the sternal marrow showed 
these cells to be present in focal collections surrounded by normal marrow cells. Terminally, 
they were found diffusely replacing a major portion of the marrow elements (Figs. 4 to 6). In 
the spleens these cells were present in both follicles and red pulp.  In nearly all instances of 
TABLE I 
Representative White and Red Blood Counts of Infected Mice 
Cell  suspension*  Cell-free  filtrate~ 
Mouse No.  Mouse No. 
27-A-4 
8-A-2 
12-A-5 
12-A-2 
5-A-3 
21-AI-6 
Controls (8) 
Post Inoc- 
ulation 
days 
27 
33 
59 
62 
66 
88 
I 
WBC 
0o,) 
36.7 
79.4 
65.2 
200.4 
158.6 
184.3 
16.1 
RBC 
(1o*) 
9.2 
9.3 
10.2 
5.1 
6.8 
8.6 
11.2 
1-15-4 
I-5-2 
XV-5-1 
XVI-1-2 
XV-l-5 
IX-I-2 
Post  Inoc- 
ulation 
days 
43 
45 
50 
63 
67 
81 
WBC 
(lo*) 
43.4 
98.8 
80.6 
136.8 
337.4 
230.0 
RBC 
(lOq 
13.4 
10.4 
14.3 
8.7 
5.5 
4.7 
* 0.2 ml. supematant of 10 per cent suspension, i.p. 
0.2 ml. of 10 per cent filtrate, i.p. 
marked involvement the demarcation of the follicles and pulp was lost and almost the entire 
spleen was replaced by these abnormal cells (Figs. 7 and 8). The liver  was involved in a simi- 
lar manner (Figs. 9 to 12). The sinusoids were widely distended by immense numbers of the 
large mononuclear cells and there was marked atrophy of the hepatic cords. In some areas the 
organ could barely be recognized as such because of the extensive infiltration. In a  few in- 
stances focal collections of cells of the same sort were found in the kidney (Fig. 13). In the 
lungs (Fig. 14) there was a widespread infiltration of the alveolar walls with the characteristic 
mononuclear cells.  The alveolar spaces were diminished in size and  occasional tumor cells 
could be seen lying free in the blood vessels. The lymph nodes showed only moderate involve- 
ment  by these cells,  and  massive enlargement of them  did not occur. In all the involved 
organs, as well as the peripheral blood, varying numbers of normoblasts were seen. No signifi- 
cant changes have been noted in other organs. 
An  interesting  manifestation  of  the  disease  was  the  occasional  appearance 
of ascites in addition to the other pathological changes. An attempt  was made 
to  start  up  an  ascites  line of  the  disease. CHARLOTTE  ~P~IEND  311 
Five ml. of slightly turbid fluid were withdrawn which on examination contained the same 
type of large mononuclear cell observed in the peripheral blood of the mice term|n~lly. These 
cells were morphologically distinct from the cells of the Ehrlich tumor. The ascites has ap- 
peared as early as 1 month after injection of these cells, and the disease was transferred by 
means of it for five serial passages. At autopsy of mice with ascites the peritoneal linings did 
not appear abnormal nor were there any patches of solid tumor. After the fifth passage, for- 
marion of ascites failed to occur, yet the disease had been transmitted as evidenced by the 
appearance of enlarged livers and spleens at death. 
Transmission  of tke Disease 
Two  serial passages  of the  disease  are  being  maintained concurrently in 
adult  Swiss  mice. One passage is made by transferring intact cells and the 
other by transferring cell-free filtrates of infected spleens. 
Cell Transfers.--For the first transfers the mice were from 2 to 7 months of 
age at the time of injection. Later mice approximately 2 months of age and 
with a  uniform weight of 16 to 20 gin. were used, and they yielded a  higher 
percentage of positives. 
Routine cell passages are carried out by preparing a 10 per cent suspension of finely minced 
infected spleen in Locke-Ringer's solution. After low speed eentrifugarion to remove coarse 
particles, 0.2 ml. of the supematant fluid is injected intraperitoneally into mice. The number 
of ceils in the inoculum is generally about 10 million. It is of interest to note that inoculation 
of only 100 or 1,000 cells has failed to produce the disease during a  10 month observation 
period. 
Cell-Free Transfer.--The first passage presumably free from cells was carried 
out by means of an extract of spleens of the third transfer generation. Since 
then serial transfers have been made with filtrates. 
For these passages the spleens are ground in a mortar and a 10 per cent suspension in Locke- 
Ringer's solution is prepared. After low speed centrifugation the supematant is removed. For 
each 10 ml. of supematant fluid 0.2 ml, of a 24 hour nutrient broth culture of ~..sckoric,  kia coli 
is added. The supematant  E. coli mixture is then filtered through Selas 03  or Berkefeld N 
filter candles. The agent has also been found to pass through gradocol membranes  s with a pore 
size of 220 m/~. Samples of the material before and after filtration are inoculated into tubes of 
nutrient broth to provide a check on the retention of bacterial cells by each filter. The filtered 
fluid--free from E. coli---readily  transmits the disease.  Serial cell-free passages are kept up 
by intraperitoneal injection of 0.2 ml. of newly prepared spleen filtrate. 
The results of serial transmissions through twenty-six passages by means of 
filtered fluid and cells  respectively are summarized in Table II. As with the 
median day of death (Text-fig. 1), there is a marked similarity in the number 
of positive animals, whether inoculated with intact cells or with cell-free fil- 
trate.  The  increasing percentage of positive  takes  in  the  later passages,  as 
compared  with  the  earlier  ones might be  considered a  manifestation of an 
increasing "adaptation" of the filterable agent to the host, as frequently occurs 
Gradocol membranes were obtained from Dr. Fred Himmelweit, London. 312  CELL-FREE  TRANSMISSION OF  A  MOUSE LEUKEMIA 
with newly isolated viruses. However, the results may merely have been due 
to  more  uniformly susceptible groups  of animals. 
Another point of comparison was available in the titration of the infective 
agent present in the superantant fluid from a  suspension of minced cells and 
TABLE H 
Results of Passages 
Serial transmission of the disease by means of spleen cell suspensions or cell-free filtrates. 
Material  from: 
Passages 1-10. 
Passages 11-20.. 
Passages 21-26. 
Cell suspension 
No. mice 
inoculated 
129 
119 
70 
No. 
positive 
72 
99 
63 
Positive 
per cent 
55.8 
83.1 
90.0 
Cell-frce  filtrate 
No. mice 
inoculated 
94 
125 
59 
No. 
posit~e 
63 
106 
53 
Positive 
per cent 
67.0 
84.8 
89.8 
TABLE HI 
T~er of tI~ Agent in Inf~I  Sple,~* 
Supemataut of cell homogenate  Filtrate of supematant 
Dilutions 
10-1 
10-2 
l0 s 
10-4 
10-~ 
No. mice  No. mice 
inoculated  positive 
5  4 
5  3 
5  4 
5  2 
5  2 
No. mice  No. mice 
inoculated  positive 
5  5 
5  5 
5  3 
5  0 
5  0 
LD~  10  -s'e  10  -a't 
* Spleen from mouse sacrificed 21 days after inoculation. 
0.2 ml. of each dilution, i.p. 
a  filtrate from the same material. Results of such a  comparative titration are 
given in Table HI. It will be seen that  the LD6o with  the minced cells was 
10  -s.8 and,  with  the filtrate, 10-~-L 
Routes  of InoculatDn.--The  mice  can  be  infected  by  the  intraperitoneal, 
subcutaneous,  intracerebral, and intramuscular routes. In mice inoculated by 
the three latter routes the onset of the disease is delayed several days, as coln- C_~Ar,  LoTr~  Yl~n~D  313 
pared  with  those  inoculated  intraperitoneally,  but  the  course remains  essen- 
tially the same. No tumor forms at the site of inoculation, yet the generalized 
leukemia-like  disease  develops.  This  is  not ~  unique,  since  it  is  known  that 
local growths in some mouse leukemias  may be small  or absent  (13). Trans- 
mission by direct contact does not appear  to take place; control mice in the 
same cage as those inoculated have remained  in good health  throughout  the 
course  of the  disease.  The disease  can be  transmitted  to infant  mice,  using 
TABLE IV 
The Transmi~slon of tI~ Disease by Inoculation of Homogena~s of Various Organs Obtaind 
from Infected Mice* 
Orgaat  No. inoculated  No. positive  Positive 
Spleen ..... 
Whole blood. 
Kidney ...... 
Lymph nodes... 
Lung 
Liver  ........ 
Heart. 
Brain. 
Skin ..... 
10 
8 
10 
10 
10 
10 
4 
10 
5 
10 
8 
10 
8 
8 
7 
2 
4 
2 
100 
100 
100 
80 
80 
70 
50 
40 
40 
* Sacrificed 16 days after inoculation. 
0.2 ml. i.p. of supernatant of 10 per cent homogenate. Blood undiluted. 
any of the methods described for adult mice, and death occurs within  2  to 3 
months  following  inoculation  as  in  adult  animals.  There  is  no  marked  de- 
pendence of transmissibility  on age or sex of the mice. 
Transmissian  with  Tissues  Other  Than  Splven.--In  two  separate  experi- 
ments  the  fact  has  been  demonstrated  that  the  disease  can  be  transmitted 
with  the  cells  of  other  organs  besides  the  spleens  from  infected  mice.  The 
results of these experiments are presented in Table IV. 
Sixteen days after inoculation three mice were bled from the heart to exsanguinate them 
in so far as feasible and then killed by dislocating the neck. The organs listed in the table were 
removed aseptically from each animal and those of the same sort were pooled for test.  Each 
suspension was injected intraperitoneany  in 0.2 ml. amounts. Preparations  from kidney and 314  CELL-FREE  TRANSMISSION  OF  A  MOUSE  LEUKEMIA 
whole blood, as well as spleen, transmitted the disease to all of the inoculated mice. The sus- 
pensions from liver, lung, and node were 70 to 80 per cent positive, whereas those from brain, 
heart, and skin ranged between 40 to 50 per cent. 
The  experiments  show  only  the  distribution  of  infective  material  in  the 
different organs, since the supernatants from  suspensions were tested instead 
of filtrates. 
Susceptibility of Other Strains of Mice besides the Swiss.--Seven  strains of 
adult mice have been tested, and thus far only the Swiss and the DBA/2 have 
developed the disease. A  line is being maintained in the latter strain as well 
TABLE V 
Stability of the Agent 
Treatment 
K-ray (50,000  r) 
Lyophyllzed (3 mos.). 
i°C. (11 days). 
-70°C. (6  mos.). 
56°C. (30 rain.) 
Ether (overnight, 4°C.). 
Formalin (1:200). 
Material. 
Whole spleen 
Filtrate 
tt 
tt 
tt 
tt 
No. 
inoculated 
20 
10 
10 
10 
10 
15 
20 
No. 
positive 
17 
10 
7 
6 
0 
0 
0 
Positive 
p~cent 
85 
IO0 
70 
6O 
0 
0 
0 
as in the Swiss. Adult animals of the PRI,  CaTB1/6,  A,  Call, and  FI(Css X 
BALB) strains proved resistant. 
Stability of the Agent 
A  small series of experiments have  been  carried out  to  learn the stability 
of the agent to certain physical and chemical treatment. Of particular interest 
is  the  marked  resistance  of the  agent  to  massive doses  of irradiation lethal 
to tumor cells (14, 15). 
Two equal portions of each of several infected spleens were  pooled,  weighed,  cut into 
millimeter cubes, and placed in two Petri dishes containing moistened filter paper. One dish 
was set aside as a control, and the other irradiated. Two 180 kv. tubes were used, one above 
and one below the dish. Mter exposure to 50,000 r the irradiated and non-irradiated tissues 
were each ground and enough Locke-Ringer solution added to make a 10 per cent concentra- 
tion, based on the original net weight.  Mice were inoculated intraperitoneally with 0.2 ml. 
amounts of one suspension or the other. Both caused the usual disease and no difference what- CHARLOTTE  FR.I:END  315 
ever could be seen in the infectivity of the irradiated material as compared with the control. 
Pooled results of two experiments carried out in the same way are shown in Table V. Further 
experiments to find out the limits of resistance to radiation are in progress, and they indicate 
that splenic fragments exposed to 100,000 or 150,000 r retain infectivity. In these later studies 
spleens from mice with transplantable leukemia 82B, a stem cell leukemia which yields no 
virus, have served as an additional control. The viability of the 82B leukemia cells was de- 
stroyed by the doses of irradiation. 
TABLE VI 
Lack of Immunological Rdationship between the Agent and LCM 
A 
Neutralization Test* 
Normal serum  Anti-LCM scram 
Agent ...................... 
LCM ...................... 
No. deaths/No. 
inoculated 
20/20 
20/20 
Positive 
per cent 
100 
100 
No. deaths/No.  Positive 
inoculated 
per cent 
18/19  94.7 
0/20  o 
* 0.03 ml. i.c. of serum-virus mixture after incubation at 37°C. for 11/~ hours. 
B 
Protection Test 
Inoculum 
Agent* ..................... 
LCMJ/: .................... 
Control mice 
No. deaths/No.  Positive  inoculated 
per cent 
14/15  93.3 
20/20  100 
LCM-immunized mice 
No. deaths/No. 
inoculated 
17/19 
o/19 
Positive 
per Cent 
89.6 
* 0.03 ml. i.c. of 10  -1 dilution of spleen filtrate. 
0.03 ml. i.c. of 10  -s dilution of LCM-infected brain. 
Other data on the stability of the agent are included in Table V.  Filtrates 
of infected spleens were still active after storage at --70°C. for 6 months and 
for at least  11  days at 4°C.  Filtrates of  10  per cent suspensions of infected 
spleen retain their infectivity when lyophilized and stored for 3  months, as 
shown when they are reconstituted with Locke-Ringer's solution and inocu- 
lated into mice. 
The infectivity of the agent is destroyed by heating at 56°C. for 30 minutes, 
by overnight exposure to ether at 4°C., and by treatment with a  1:200 dilu- 
tion of formalin. 316  CELL-FREE  TRANSMISSION  OF  A  MOUSE  LEUKEMIA 
In view of the experiences of Stewart and Haas (16) and of many virologists 
who have encountered lymphocytic choriomeningitis (LCM) as a  latent virus 
in their experimental animals,  it seemed desirable to find out whether there 
was any immunological relationship between LCM and the agent under dis- 
cussion. This was done despite the fact that LCM gives rise to a disease wholly 
different from that dealt with here (16). 
Tests of  two types  were carried  out.  Forty mice were given an intraperitoneal  inoculation 
of  a i0  per  cent brain suspension of  the  Armstrong  3 strain  of  LCM  containing approximately 
three  million  intracerebral  LD60 doses.  Twenty other animals were set  aside  for  normal con- 
trols.  After  3 weeks the  Immu~  animals  were divided  into  four  equal  groups.  Those of  one 
group were bled to obtain immune serum for in ~ro neutralization  tests.  Two groups were 
used  for  protection  tests  and the  fourth  group  was  held to  observe whether  any  LCM-injected 
animals  would show characteristics  of the disease  now under consideration. 
For the in ~/~ro  neutralization  test  a filtrate  of a 20 per cent brain suspension of  LCM  or 
a filtrate  of  a 20  per  cent suspension of  infected  spleen  was each  mixed with  an equal quantity 
of  undiluted normal  mouse serum  or  LCM  immune serum. The mixtures  were  held for  one  and 
a half  hours at 37°C., after  which each was inoculated intracerebrally  in 0.03 ml. amounts 
into  groups of ten mice each.  Deaths occurring  within the first  24 hours were discarded from 
the  results.  The pooled  results  of  two  experiments are  shown in  Table  VI (A).  LCM  antiserum 
failed  to neutralize  the splenic  agent,  while it  completely  neutralized  LCNI virus. 
For the in ~vo protection test a 10  -3 dilution of LCM-infected  brain (approcimately  30,000 
ic.  LDs0,s) was inoculated intracerebrally  into LCM  immune mice and ten normal mice of 
the  same age. Similarly  a I0  per  cent dilution  of  splenic  filtrate  was inoculated  intracerebraUy 
into LCM-immune  and normal mice. The pooled results  of two experiments, presented in 
Table VI (B), confirm the neutralization test findings. The LCM-immune mice were fully 
susceptible to the splenic agent but resisted LCM infection. All surviving animals from both 
series of experiments  are still being observed. Five months have passed with one series and 
three months with the other, and thus far the LCM-immunized mice, followed since the 
beginning of the experiments,  have shown no evidence  of leukemia or LCM. 
DISCUSSION 
A  first question to be asked concerns the nature of the disease described: 
Is  it  a  true  leukemia?  The  pathological findings  resemble  those  associated 
with  leukemia  instead  of  ordinary  extramedullary  myelopoiesis  (17).  The 
disease  is  characterized  by marked  proliferation of  immature  mononuclear 
cells which invade the spleen, liver, bone marrow, kidney, and lung, and ap- 
pear in the peripheral blood. These large cells can be seen in various stages of 
mitosis in the organs they infiltrate. Terminally, the mice have greatly ele- 
vated white blood counts, are anemic, and have tremendously enlarged spleens 
and livers. 
The second  question  concerns  the  agent  producing  the  disease:  What  is 
its nature? Its viral character is indicated by the following evidence: (a) The 
disease can be transmitted serially by means of extracts passed through filters 
3  The Armstrong  strain of LCM was obtained from the American  Type Culture Association. CaZAR~OTZZ F~ND  317 
which hold back E. coll.  (b)  The agent causing it is resistant to an exposure 
to x-ray many times that needed to destroy normal cells of the same kind. 
(c) When dried,  the agent retains its activity for long periods. 
Graffi, Bielka, and Fey (18), and Schmldt (19), state that they had prepared cell- 
free filtrates from their strains of the Ehrlich ascites tumor which will induce leukemia 
if inoculated into newborn Agnes Blnhm mice. However, their findings differ from the 
ones described in this report in at least three respects: (a) The agent of the disease now 
under consideration  has a much shorter period of latency. (b) It produces the disease 
in adult animals.  (c) It can be passed serially in such animals. 
Though  the present agent was primarily recovered from a diseased Swiss 
mouse inoculated in infancy with material from the Ehrlich ascites tumor, 
this tumor itself  has not appeared in over 400 mice examined after  injection 
with the agent. Whether this  was latent  in the Ehrlich tumor cells  or its  pres- 
ence together with the tumor was accidental  is still  not clear  and must await 
further study. The possibility  of the agent being the cause of a spontaneous 
disease which developed sometime during the 14 month  observation of the 
original mouse should be considered. 
SUrf  MARY 
A disease with the characteristics of a leukemia has been found to be serially 
transmissible in adult Swiss mice by means of ceU-free filtrates. Thus far, the 
disease has been transmitted through twenty-six serial passages with filtrates 
as  well  as  cell  suspensions.  The  agent  readily  passes  through  Selas  03, 
Berkefeld N,  and  gradocol membrane  filters--these last  having  an  average 
pore size of 220 m#.  Filtrates remain stable when stored for long periods at 
--70°C.  or when lyophilized. Splenic tissue containing the agent,  which was 
subjected to massive doses of x-ray (50,000 r),--far more than sufficient to 
kill  the  cells,--sho@  undiminished  infectivity. The  agent  is  inactivated  by 
heating to 56°C. for 30 minutes and by exposure to ether or formalin.  " 
The disease can be transmitted  to adult  Swiss mice or DBA/2  mice, but 
not  to adult  PRI,  CffI,  A,  C57B1//6, or FI(C~  X  BALB)  mice.  Intraperi- 
toneal,  subcutaneous,  intracerebral,  and  intramuscular  injections  are  all 
effective. 
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EXPLANATION OF PLATES 
All sections were stained with hematoxylin and eosin, and the blood and impression 
smears with tetrachrome. 
PX.AT~ 24 
FIG. 1. Peripheral blood of mouse bled on the 88th day after inoculation with the 
agent. The WBC was 184,350 cells/mm  s, and the RBC 8,860,000 cells/mmA X  1350. 
FIo. 2. Peripheral blood of mouse bled on the 81st day after inoculation.  The WBC 
was 230,000 cells/mm?, and the RBC was 4,700,000 cells/mmA Polymorphonudear 
leukocytes, lymphocytes, and the abnormal mononudear cells are present. ×  820. 
FIG. 3. The mouse on the left was found dead 57 days after inoculation. There is 
marked enlargement of liver and spleen. The mouse on the right is an uninjected con- 
trol of the same age. THE  ~OURNAL  OF EXPERIMENTAL  MEDICINE  VOL.  105  PLATE  24 
(Friend: Cell-free transmission of a  mouse leukemia) PLATE  25 
FIO. 4. Sternal marrow of mouse whose blood picture is shown in Fig. 1. It is crowded 
with large mononuclear cells.  X  200. 
FIG.  5.  Portion  of the  same  at  higher  magnification,  showing  large  mononuelear 
cells with vesicular nuclei. Mitotic figures are evident.  ><  920. 
FIG.  6.  Impression  of femural  marrow  from  the  same  mouse  showing  the  mono- 
nuclear cells, some of which are in mitosis.  X  1350. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  105  PLATE 25 
(Friend: Cell-free transmission of a  mouse leukemia) PLATE  26 
FIG.  7.  Spleen from the same mouse showing a  loss of demarcation of the follicles 
and  the red pulp.  X  300. 
FIG. 8. Part of the same at a higher power.  ×  400. 
FIG. 9. Liver. Perivascular infiltration in the liver of a mouse sacrificed 60 days after 
inoculation.  ×  300. 
FIG.  10.  The same at a  higher magnification.  X  400. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  105  PLATE  26 
(Friend: Cell-free transmission of a  mouse leukemia) PLATE  27 
FIG.  11.  Liver.  Greatly  involved liver of mouse  killed  88  days  after  inoculation 
whose spleen is shown in Fig.  7.  There is massive infiltration and  few of the hepatic 
cords remain.  X  300. 
FIG.  12.  Impression  o~ same liver showing numerous  large mononuclear  cells,  two 
of them in mitosis, as well as part of two normoblasts.  ×  1350. 
FIG.  13. Kidney: showing a focal collection of cells in the renal cortex.  X  300. 
FIG. 14. Lung: infiltration of the alveolar walls is to be seen and many free mononu- 
clear cells lying in a  blood vessel are seen.  X  200. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  105  PLATE  27 
(Friend : Cell-free transmission of a  mouse leukemia) 